Spain - Re-Imbursed Pharmaceutical Market
Since 2014, Spain Re-Imbursed Pharmaceutical Market was up 1.6points year on year. In 2019, the country was number 10 comparing other countries in Re-Imbursed Pharmaceutical Market with 23.6 Percent of Generics in Value. Spain is overtaken by Portugal, which was ranked number 9 at 25 Percent of Generics in Value and is followed by Denmark at 21.5 Percent of Generics in Value. Austria ranked the highest with 52.2 Percent of Generics in Value in 2019, +2.8points compared to 2018. United Kingdom, Turkey and New Zealand respectively ranked number 2, 3 and 4 in this ranking. Denmark recorded the best 5 years average growth at +6.9points per year, while Slovakia was the worst growing country at -7.8points per year.
Loading...
| Date | Percent of Generics in Value |
|---|---|
| 2019 | 23.60 |
| 2018 | 22.40 |
| 2017 | 22.30 |
| 2016 | 22.50 |
| 2015 | 22.70 |
How does Spain rank in Re-Imbursed Pharmaceutical Market?
| # | 17 Countries | Percent of Generics in Value | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Austria
|
52.20 % | 2019 | +2.8 % | +2.2 % | View data | |
| 2 |
#2
United Kingdom
|
38.50 % | 2019 | +2.1 % | +2.6 % | View data | |
| 9 |
#9
Portugal
|
25.00 % | 2019 | -1.6 % | +0.7 % | View data | |
| 10 |
#10
Spain
|
23.60 % | 2019 | +5.4 % | +1.6 % | View data | |
| 11 |
#11
Denmark
|
21.50 % | 2019 | +14.4 % | +6.9 % | View data | |